Interleukin-6 and mevastatin regulate plasminogen activator inhibitor-1 through CCAAT/enhancer-binding protein-delta. [electronic resource]
Producer: 20051229Description: 1078-84 p. digitalISSN:- 1524-4636
- Animals
- Atherosclerosis -- drug therapy
- CCAAT-Enhancer-Binding Protein-delta -- genetics
- Carcinoma, Hepatocellular
- Cell Line, Tumor
- Cell Nucleus -- physiology
- Chromosome Mapping
- Gene Expression -- drug effects
- Hepatocytes -- drug effects
- Humans
- Hydroxymethylglutaryl-CoA Reductase Inhibitors -- pharmacology
- Interleukin-6 -- genetics
- Liver Neoplasms
- Lovastatin -- analogs & derivatives
- Mice
- Mice, Inbred ICR
- Mutagenesis, Site-Directed
- Plasminogen Activator Inhibitor 1 -- genetics
- Promoter Regions, Genetic
- RNA, Messenger -- metabolism
- Response Elements
- Thrombosis -- physiopathology
- Transfection
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.